Home / Business and Economy / Inside High-Stakes Drug Manufacturing: Authors Reveal
Inside High-Stakes Drug Manufacturing: Authors Reveal
1 Jul
Summary
- Book delves into the complex realities of pharmaceutical manufacturing.
- Authors share insights on regulatory compliance and entrepreneurship challenges.
- Highlights India's significant role in global generic medicine supply.
Abhinav Garg and Mehak Aggarwal, entrepreneurs in the pharmaceutical industry, have released their book, 'Killing Cancer: 13 Secrets of the High-Stakes Drug Manufacturing World.' This work provides an unprecedented look into the demanding field of pharmaceutical manufacturing.
The book is structured around 13 chapters, detailing subjects from regulatory adherence and supply chain resilience to entrepreneurial challenges and quality systems. The authors stress that obtaining a drug license is merely the beginning, emphasizing the continuous need for World Health Organization-Good Manufacturing Practices (WHO-GMP) compliance and supplier validation.
'Killing Cancer' is intended for a broad audience, including entrepreneurs, industry professionals, and the public. It aims to demystify the journey of medicines from production to patients, highlighting the critical decisions, regulations, and human judgment involved.
The authors also touch upon India's significant position as a leading global supplier of generic medicines. They underscore the importance of manufacturing hubs like Baddi and the evolving industry landscape toward complex generics and personalized medicine. The book is dedicated to their daughter, symbolizing hope for a safer future healthcare ecosystem.
